Who owns the EXONDYS 51 ETEPLIRSEN INJECTION trademark?

The EXONDYS 51 ETEPLIRSEN INJECTION trademark is owned by Sarepta Therapeutics, Inc..

What class is the EXONDYS 51 ETEPLIRSEN INJECTION trademark registered in?

The EXONDYS 51 ETEPLIRSEN INJECTION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EXONDYS 51 ETEPLIRSEN INJECTION?

The USPTO serial number for EXONDYS 51 ETEPLIRSEN INJECTION is 87175636.

What is the registration number for EXONDYS 51 ETEPLIRSEN INJECTION?

EXONDYS 51 ETEPLIRSEN INJECTION is registered under USPTO registration number 6059005.

EXO

USPTO Trademark Record

REGISTERED

EXONDYS 51 ETEPLIRSEN INJECTION

SN 87175636·Reg 6059005·Filed Sep 19, 2016

Owner Sarepta Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EXONDYS 51 ETEPLIRSEN INJECTION (Serial No. 87175636), Registration No. 6059005, is a registered US trademark filed on Sep 19, 2016 by Sarepta Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: May 20, 2030

Mark Intelligence

EXONDYS 51 ETEPLIRSEN INJECTION (Reg. #6059005) is a registered US trademark that has been protecting its owner, Sarepta Therapeutics, Inc., since 2016. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 19, 2016

SERIAL

87175636

REG#

6059005

REGISTERED

May 19, 2020

Owner

Applicant

Sarepta Therapeutics, Inc.

Entity

Corporation

State

Address

215 First Street, Cambridge, MA, 02142

Country

Attorney

NameMaury M. Tepper, III

Law firm

Maury M. Tepper, III TEPPER & EYSTER, PLLC

Address

3724 BENSON DRIVE, RALEIGH, NC 27609, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 19, 2016

Serial Number87175636

Registration No.6059005

Registration DateMay 19, 2020

Status DateAug 13, 2026

Published for OppositionFeb 21, 2017

Next RenewalMay 20, 2030

Mark TypeDesign with words

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2016

YEARS AGO

10y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Mar 26, 2020

First use in commerce: Mar 26, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

49 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 13, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Aug 13, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Aug 13, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

May 07, 2026

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 19, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jul 22, 2020

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED-PRINCIPAL REGISTER

May 19, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 14, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 11, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Apr 07, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Mar 31, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 31, 2020

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 27, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 26, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Sep 26, 2019

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Sep 23, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Sep 23, 2019

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 20, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 18, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Apr 18, 2019

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Apr 18, 2019

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 16, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 12, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Oct 12, 2018

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Oct 12, 2018

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 31, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 29, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Mar 29, 2018

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Mar 29, 2018

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 20, 2017

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 18, 2017

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Oct 18, 2017

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Oct 18, 2017

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 18, 2017

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 21, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 21, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 01, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jan 16, 2017

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 16, 2017

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 16, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 16, 2017

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 16, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Jan 13, 2017

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 13, 2017

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 13, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 23, 2016

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 24, 2016

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 23, 2016

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 22, 2016

NEW APPLICATION ENTERED

EXONDYS 51 ETEPLIRSEN INJECTION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Sarepta Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Maury M. Tepper, III

Resources

Company